Next |
home / stock / vbiv / vbiv message board
Subject | By | Source | When |
---|---|---|---|
$VBIV no 1 in the Gaucho session | Monksdream | investorshub | 07/05/2023 8:23:32 PM |
Zoom Zoom WOOHOOOOOO WOOHOOOOOO $VBIV | weedtrader420 | investorshub | 07/05/2023 8:12:19 PM |
$VBIV: BBOOoooommmmmmmmm.............. moved now to $3.50 | makinezmoney | investorshub | 07/05/2023 8:02:51 PM |
$VBIV where is the squeeze? | cheynew | investorshub | 07/04/2023 4:43:59 PM |
$VBIV The gaining | cheynew | investorshub | 07/04/2023 11:59:28 AM |
What happened | phillymillions | investorshub | 07/02/2023 10:49:49 PM |
$VBIV Lets go go go go... Up up and away we go. | TIZZUNI | investorshub | 07/02/2023 8:09:10 PM |
The gaining up | cheynew | investorshub | 07/02/2023 7:03:23 PM |
$VBIV Price now | cheynew | investorshub | 07/02/2023 5:24:05 PM |
Big day on Monday | amitgupta | investorshub | 07/02/2023 12:06:59 AM |
MomentumIts now | cheynew | investorshub | 07/01/2023 2:45:39 AM |
Wild | Awl416 | investorshub | 06/30/2023 6:35:20 PM |
Yup | Awl416 | investorshub | 06/30/2023 6:17:29 PM |
Have a look at this | cheynew | investorshub | 06/27/2023 7:12:35 AM |
$VBIV The now | Atlanta1 | investorshub | 06/24/2023 4:37:34 AM |
short data if anyone is interested | MADDSTACKER | investorshub | 06/24/2023 1:44:57 AM |
got some short data | cheynew | investorshub | 06/23/2023 2:22:27 AM |
$VBIV MomentumIts trading | cheynew | investorshub | 06/22/2023 10:41:35 PM |
best news of the day | MADDSTACKER | investorshub | 06/22/2023 5:57:28 PM |
Price gaining | MERCURIAL | investorshub | 06/22/2023 4:18:34 PM |
News, Short Squeeze, Breakout and More Instantly...
Among the 7 patients on VBI-1901 treatment long enough to have 1+ MRI scan at the time of analysis, one partial tumor response (PR) and two stable disease (SD) observations have occurred as of May 15, 2024 The partial response, which demonstrated a 67% reduction in tumor size vs. baseline, wa...
VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that new interim tumor response data from the ongoing randomized, controlled Phase 2b study of VBI-1901, the Company’s ca...
PreHevbrio ® (Hepatitis B Vaccine [Recombinant]) global net revenue increased 105% year-over-year in the first quarter of 2024 compared to the first quarter of 2023 Initial encouraging tumor response data from randomized Phase 2b study of VBI-1901 in recurrent glioblastoma (GBM) anno...